• Mashup Score: 0

    A cardio-oncology rehabilitation program can benefit cancer survivors with a high risk of cardiovascular disease, according to a new study published in JAMA Cardiology. Heart disease is a leading cause of death in cancer survivors, making it crucial to develop strategies for mitigating cardiovascular risk. In this study, researchers sought to assess whether a center-based cardiac rehabilitation (CBCR) framework is superior to usual care encompassing community-based exercise training (CBET). In the

    Tweet Tweets with this article
    • A cardio-oncology rehabilitation program can benefit cancer survivors with high cardiovascular disease risk. #cardiooncology #cancersurvivors #cvd #heartdisease https://t.co/HuPSBnlDc5 https://t.co/AmtPVuo9SX

  • Mashup Score: 0

    In an Australian phase III trial (TARGET-TP) reported in JAMA Oncology, Alexander et al found that ambulatory thromboprophylaxis reduced the risk of thromboembolic events in patients starting systemic therapy for lung or gastrointestinal cancer who were at elevated risk of thrombosis. The multicenter trial included 328 patients initiating systemic anticancer therapy for gastrointestinal cancer (n = 201) or lung cancer (n = 127) beginning in June 2018; a total of 132 patients had metastatic disease.

    Tweet Tweets with this article
    • Ambulatory Thromboprophylaxis in Patients With Cancer https://t.co/JJiQIWwXva #cancer #cardiooncology

  • Mashup Score: 1

    In this broadcast entitled ‘Cardiac Imaging to Detect Cardiotoxicity From Proteasome Inhibitors in Alignment with ESC Guidelines’ the faculty will be addressing the critical balance between therapeutic progress and cardiac safety in oncology. Exploring cutting-edge cardiac imaging techniques, their applications and their integration with ESC’s guidelines to ensure patient safety and optimise clinical outcomes.

    Tweet Tweets with this article
    • ⚖️Explore the critical balance between therapeutic progress and cardiac safety in oncology in our next #CardioOncology broadcast. đź”—Register now https://t.co/hNtzjzksoj Renowned faculty delve into: âś…Cutting-edge cardiac imaging techniques âś…Applications âś…Integration with… https://t.co/iJi2XiPXZZ https://t.co/KBPhrWDGBF

  • Mashup Score: 1

    Patients with a history of or active cancer had a higher rate of acute MI when presenting to the ED with chest pain, a speaker reported.The European Society of Cardiology 0/1-hour algorithms demonstrated high safety for the detection of acute MI in patients with cancer compared with no cancer; however, their efficacy was reduced due to more patients with cancer remaining in the observation zone,

    Tweet Tweets with this article
    • ICYMI: “Patients with cancer have a substantially higher prevalence of acute MI when presenting with acute chest discomfort to the ED,” @ACCinTouch @HemOncToday #ESCCongress @ESCardioNews #cardiotwitter #CardioOncology https://t.co/PqfrdhijSj